(Total Views: 365)
Posted On: 04/23/2017 9:13:51 PM
Post# of 15624
The results of this conference might be felt over years as relationships are built and future funding might come from those relationships.
Some very successful biotech's still routinely fund new development. Even with substantial revenue coming in, developing new drugs or adding manufacturing capability often requires new funding vehicles.
I'm uncertain what OWCP would want to bring in at this time. I would hope it's not more than a few million with the current stock price. The time may come when we need hundreds of millions, but I'd hope that by that time we have a share price somewhere in the mid double digit range where a few million shares could bring in a hundred million, or more.
Gary
Some very successful biotech's still routinely fund new development. Even with substantial revenue coming in, developing new drugs or adding manufacturing capability often requires new funding vehicles.
I'm uncertain what OWCP would want to bring in at this time. I would hope it's not more than a few million with the current stock price. The time may come when we need hundreds of millions, but I'd hope that by that time we have a share price somewhere in the mid double digit range where a few million shares could bring in a hundred million, or more.
Gary
(0)
(0)
